Form 10-Q · Quarterly report
Occidental Petroleum 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0000797468
- Accession no.
- 0001628280-26-053388
Summary
Occidental Petroleum raised its quarterly dividend 8% to $0.28 per share, payable October 15, 2026, and completed the all-cash sale of OxyChem on January 2, 2026 at a $9.5 billion adjusted price for a gain of about $3.1 billion. The company said its average WTI price per barrel was $92.79 in the second quarter of 2026 versus $71.93 in the first quarter, with second-quarter prices helped in part by risk premiums tied to the conflict involving Iran, while tariffs and geopolitical uncertainty remain risks to costs and demand.
Key points
- Occidental's average WTI price per barrel was $92.79 in the three months ended June 30, 2026, up from $71.93 in the prior quarter.
- For the six months ended June 30, 2026 the average WTI price was $82.36, compared with $67.58 a year earlier.
- The board raised the quarterly dividend 8% to $0.28 per share, payable October 15, 2026 to shareholders of record September 10, 2026.
- The OxyChem sale closed January 2, 2026 for an adjusted cash price of $9.5 billion, producing a gain of roughly $3.1 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion should be read together with the Consolidated Condensed Financial Statements and the notes to the Consolidated Condensed Financial Statements, which are included in this report in Part I, Item 1; the information set forth in Risk Factors under Part II, Item 1A; the Consolidated Financial Statements and the notes to the Consolidated Financial Statements, which are included in Part II, Item 8 of the 2025 Form 10-K; and the information set forth in Risk Factors under Part I, Item 1A of the 2025 Form 10-K. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.